Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

A circulating tumor DNA (ctDNA) blood test demonstrated high sensitivity and specificity for colorectal cancer (CRC) detection in a large average-risk population, study finds.

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

Guardant Health (GH) announced that the National Comprehensive Cancer Network, NCCN, has included the Shield blood test in its updated colorectal ...